Company Statements | Merck Newsroom Home

Company Statements

4/9/13 8:30 am EDT
Statement on FOSAMAX® (alendronate sodium) Product Liability Trial
3/18/13 12:49 pm EDT
Mistrial Declared in FOSAMAX® (alendronate sodium) New Jersey State Court Trial
3/14/13 5:16 pm EDT
Merck Provides U.S. Regulatory Update on Sugammadex Sodium Injection
3/14/13 4:43 pm EDT
Merck Stands Behind the Safety Profile of JANUVIA® (sitagliptin)
3/11/13 1:26 pm EDT
Statement on FOSAMAX® (alendronate sodium) Product Liability Trial
2/5/13 12:54 pm EST
Mixed Result in Federal Trial Involving FOSAMAX® (alendronate sodium)
1/14/13 8:30 am EST
Statement on FOSAMAX® (alendronate sodium) Product Liability Trial
12/5/12 5:00 pm EST
Merck Foundation Suspends Funding to the Boy Scouts of America
11/9/12 5:20 pm EST
Merck to Continue Work with FDA for OXYTROL® as an Over-the-Counter Treatment for Overactive Bladder in Women
4/4/12
Merck Statement On NASONEX® (mometasone furoate monohydrate) Patent Trial in the U.S. District Court for the District of New Jersey
3/28/12
Merck Provides Update on IMPROVE-IT Trial
3/20/12
Merck and ARIAD Pharmaceuticals Provide Update on FDA Advisory Committee Vote on Investigational Medicine Ridaforolimus for the Treatment of Metastatic Soft-Tissue or Bone Sarcomas
3/5/12
Merck Provides U.S. Regulatory Update on Investigational Ezetimibe/Atorvastatin Tablets
2/28/12
Merck Provides Information on FDA Post-Marketing Requirement for Sitagliptin
2/27/12
Statement on FOSAMAX® (alendronate sodium) Product Liability Trial in New Jersey
10/12/11
Full Federal Court Rules in MSD Australia's Favour in Vioxx® Case
9/13/11
Merck Statement on GARDASIL®
9/13/11
Merck Provides Update on the IMPROVE-IT Trial
7/1/11
Merck Statement on Voluntary Submission of Clinical Research Protocols for its Investigational and Approved Products
10/28/10
Merck Statement on Investigation of PCV Presented at Advisory Committee on Immunization Practices Meeting
10/14/10
Merck Statement on Remicade and Simponi Arbitration

RSS

Patients & Caregivers
Healthcare Professionals
- EngageZone
- The Merck Manual
- Merck Medicus
- Authorized Distributors
- Clinical Trials
- Supplier Diversity
Media & Investors
Job Seekers
Company Statements

Copyright © 2009- Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved.
Privacy
Terms of Use
Site Map

Business Wire NewsHQ℠